ADVERTISEMENT
#Q3WithBQ | #AartiDrugs' profit slides 37% year-on-year as formulation and specialty chemicals see revenue contraction.In conversation with CFO Adhish P Patil. #BQLive
ADVERTISEMENT
RECOMMENDED FOR YOU
Lupin Q4 Results Review - Niche Product Drives Earnings Growth: Motilal Oswal
May 08, 2024Indian Bank Q4 Results Review - Steady Quarter; Healthy Provision Buffers: Dolat Capital
May 07, 2024Mangalore Refinery Q4 Results Review - Strong GRMs Drive Earnings: Prabhudas Lilladher
May 06, 2024MRF Q4 Results Review - Weak Operational Performance: Motilal Oswal
May 06, 2024IPO Adda | Indegene Management On IPO Plans | NDTV Profit
IPO Adda | Aadhar Housing Finance MD & CEO Discusses Plans | NDTV Profit
NDTV Profit
IGX MD & CEO Rajesh Mediratta On New Small Scale LNG Contracts | NDTV Profit
NDTV Profit
TBO Tek To Launch Rs 1,550 Crore IPO | NDTV Profit
NDTV Profit
Indeed India's Sashi Kumar On Hiring Trends In India | NDTV Profit
NDTV Profit
Star Health's Q4 Report: Post-Hike Trends Discussed With Nilesh Kambli; Multiple Banking Partnerships
NDTV Profit
View All